The overarching framework of translation and integration into healthcare: a case for the LAL model

Personalized Medicine
Jonathan A LalA Brand

Abstract

Recently, there has been a substantial increase in relevant genome-based technologies into market. Compared with its utilization in healthcare systems, we notice a huge gap. In order to address this bottleneck, we previously developed the Learning-Adapting-Leveling (LAL) model. In this article, we aim to demonstrate the overarching reach of the model for translation to market and implementation into healthcare systems moving towards personalized healthcare. We use qualitative logical reasoning with the LAL model as a reference. We found that technology transfer, health needs assessment, health technology assessment and health impact assessment are justified for their inclusion. In addition, the public health wheel is justified as a good reference frame along with value of information. We conclude that as the LAL model covers all dimensions and tools for translation and implementation in a defined method; it can therefore be considered as the overarching framework for translation and implementation into healthcare.

References

May 23, 1998·BMJ : British Medical Journal·J WrightJ R Wilkinson
Sep 5, 2001·Nature Biotechnology·J J StewartR S Johnson
Nov 17, 2001·BMJ : British Medical Journal·J Parry, A Stevens
Apr 3, 2002·JAMA : the Journal of the American Medical Association·Phil B Fontanarosa, Catherine D DeAngelis
Jun 11, 2002·International Journal of Technology Assessment in Health Care·John M Eisenberg, Deborah Zarin
Apr 17, 2003·JAMA : the Journal of the American Medical Association·Donald M Berwick
Jul 10, 2003·Journal of Public Health Medicine·Andrew StevensAmanda Burls
Sep 20, 2005·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Simon SandersonJon Emery
Jul 18, 2006·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Wylie BurkeUNKNOWN Bellagio Group
May 12, 2007·International Journal of Technology Assessment in Health Care·Kirsten F L DoumaWim H van Harten
Dec 13, 2007·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Muin J KhouryLinda Bradley
Jan 10, 2008·JAMA : the Journal of the American Medical Association·Steven H Woolf
Jun 19, 2009·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Sean D SullivanScott D Ramsey
Jun 23, 2009·International Journal of Technology Assessment in Health Care·Renaldo N Battista, Matthew J Hodge
Jun 29, 2011·Clinical and Translational Science·William TrochimHarold A Pincus
Aug 31, 2011·Applied Health Economics and Health Policy·Maarten J Ijzerman, Lotte M G Steuten
Dec 7, 2011·Journal of Translational Medicine·Jonathan A LalAngela Brand
Jan 23, 2013·Annals of Oncology : Official Journal of the European Society for Medical Oncology·H A AzimC Swanton

❮ Previous
Next ❯

Citations

Dec 19, 2020·International Journal of Environmental Research and Public Health·Balázs ÁdámRóza Ádány

❮ Previous
Next ❯

Methods Mentioned

BETA
PHAT

Software Mentioned

Euroscan
LAL
RARE
TT
HTAi
EUNetHTA
EPIRARE
PHAT
PHGEN
PHG

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.